143 related articles for article (PubMed ID: 28534080)
1. Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
Lorimer PD; Motz BM; Kirks RC; Boselli DM; Walsh KK; Prabhu RS; Hill JS; Salo JC
Ann Surg Oncol; 2017 Aug; 24(8):2095-2103. PubMed ID: 28534080
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Al-Sukhni E; Attwood K; Mattson DM; Gabriel E; Nurkin SJ
Ann Surg Oncol; 2016 Apr; 23(4):1177-86. PubMed ID: 26668083
[TBL] [Abstract][Full Text] [Related]
3. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
Probst CP; Becerra AZ; Aquina CT; Tejani MA; Wexner SD; Garcia-Aguilar J; Remzi FH; Dietz DW; Monson JR; Fleming FJ;
J Am Coll Surg; 2015 Aug; 221(2):430-40. PubMed ID: 26206642
[TBL] [Abstract][Full Text] [Related]
4. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
5. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
[TBL] [Abstract][Full Text] [Related]
6. Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
Huntington CR; Boselli D; Symanowski J; Hill JS; Crimaldi A; Salo JC
Ann Surg Oncol; 2016 Mar; 23(3):877-87. PubMed ID: 26514119
[TBL] [Abstract][Full Text] [Related]
7. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
8. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
9. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
[TBL] [Abstract][Full Text] [Related]
10. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
[TBL] [Abstract][Full Text] [Related]
11. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
Runau F; Collins A; Fenech GA; Ford E; Dimitriou N; Chaudhri S; Yeung JM
Int J Colorectal Dis; 2017 Mar; 32(3):341-348. PubMed ID: 27885480
[TBL] [Abstract][Full Text] [Related]
12. Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion.
Wilkins S; Haydon A; Porter I; Oliva K; Staples M; Carne P; McMurrick P; Bell S
Dis Colon Rectum; 2016 May; 59(5):361-8. PubMed ID: 27050597
[TBL] [Abstract][Full Text] [Related]
13. NPTX2 is associated with neoadjuvant therapy response in rectal cancer.
Karagkounis G; Thai L; DeVecchio J; Gantt GA; Duraes L; Pai RK; Kalady MF
J Surg Res; 2016 May; 202(1):112-7. PubMed ID: 27083956
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
[TBL] [Abstract][Full Text] [Related]
15. Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
Geva R; Davidovics H; Soyfer S; Pelles-Avraham S; Klausner JM; Inbar M; Tulchinsky H
Colorectal Dis; 2017 Mar; 19(3):237-242. PubMed ID: 27474791
[TBL] [Abstract][Full Text] [Related]
16. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
[TBL] [Abstract][Full Text] [Related]
17. NEOADJUVANT THERAPY AND SURGERY FOR RECTAL CANCER. Comparative study between partial and complete pathological response.
Andrade VA; Coy CS; Leal RF; Fagundes JJ; Martinez CA; Ayrizono Mde L
Arq Gastroenterol; 2016; 53(3):163-8. PubMed ID: 27438421
[TBL] [Abstract][Full Text] [Related]
18. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]